Caliber Wealth Management (Utah)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,030
Closed -$217K – 91
2022
Q3
$217K Buy
+4,030
New +$207K 0.17% 62
2022
Q2
– Sell
-4,030
Closed -$267K – 69
2022
Q1
$267K Sell
4,030
-10
-0.2% -$684 0.17% 58
2021
Q4
$313K Sell
4,040
-497
-11% -$51.4K 0.22% 62
2021
Q3
$451K Hold
4,537
– – 0.32% 66
2021
Q2
$563K Hold
4,537
– – 0.4% 64
2021
Q1
$693K Hold
4,537
– – 0.5% 58
2020
Q4
$585K Buy
+4,537
New +$522K 0.57% 55

Other funds holding GH

Caliber Wealth Management (Utah)'s GH Position: Q4 2022 in Review

Caliber Wealth Management (Utah) sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,030 shares — an estimated $217K sold.

Caliber Wealth Management (Utah) first reported a position in GH in Q4 2020 and held it in 7 quarters. The position peaked at $693K in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Caliber Wealth Management (Utah) reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Caliber Wealth Management (Utah) sold 4,030 Guardant Health shares in Q4 2022, an estimated $217K.
  • Caliber Wealth Management (Utah) first reported a position in Guardant Health in Q4 2020 and held it in 7 quarters.
  • Caliber Wealth Management (Utah)'s Guardant Health position peaked at $693K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Caliber Wealth Management (Utah)'s 13F filing for Q4 2022, filed 24 Jan 2023.